Federal investigation and HHS report allege insurance‑coding fraud and retaliation in pediatric gender‑affirming care
A former nurse at Texas Children’s Hospital says she reported the use of state funds for gender‑transition procedures for minors and that FBI agents later appeared at her home. The Department of Justice has pursued the case as Medicaid fraud and illegal medical practice. A Department of Health and Human Services study titled “Wolves in White Coats” alleges that more than 225 hospitals and clinics used ambiguous billing codes, documenting roughly $50 million in puberty‑blocker claims under a generic endocrine disorder code and about $11 million for adolescents billed as having precocious puberty between 2015 and 2025.
The report also includes accounts from three former patients who say they were pressured into puberty blockers, hormone therapy and irreversible surgeries while under age 18. Vice President JD Vance, chair of the White House Task Force to Eliminate Fraud, and HHS Secretary Robert F. Kennedy Jr. have highlighted the findings as evidence of a profit‑driven market targeting minors.
How this was covered
- The two sides describe this in almost entirely different words
Why it matters
The allegations suggest that vulnerable youths may be receiving costly, irreversible medical treatments billed through questionable insurance practices, raising concerns about patient safety and public spending.
How this story developed
- Aug 13 JD Vance urges DOJ to prosecute alleged fraud in teen gender-transition care
- Aug 14 Vice President Vance has ordered a DOJ criminal investigation into the alleged billing fraud.
- Aug 18 The HHS report has been released, prompting renewed federal scrutiny of pediatric gender‑affirming programs.
